Clinical trial
Allogeneic Cell Therapy for Adults With Hematologic Malignancies
NCT00208962 · Emory University, Other · Completed
Key facts
| NCT number | NCT00208962 |
|---|---|
| Title | Allogeneic Cell Therapy for Adults With Hematologic Malignancies |
| Official title | Allogeneic Cell Therapy for Adults With Hematologic Malignancies |
| Lead sponsor | Emory University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hematologic Diseases |
| Intervention type | Procedure |
| Interventions | chemotherapy and blood stem cell transplantation |
| Enrollment | 32 |
| Start date | Sep 1, 1998 |
| Primary completion | Sep 1, 2007 |
| Completion | Aug 1, 2013 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 12, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: